Search alternatives:
significantly increases » significantly increased (Expand Search), significantly increase (Expand Search), significant increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
increases decrease » increased release (Expand Search)
Showing 3,481 - 3,500 results of 21,342 for search '(( significantly increases decrease ) OR ( significant decrease decrease ))', query time: 0.38s Refine Results
  1. 3481
    Interpolated survival in mice with or without lung metastases.

    Interpolated survival in mice with or without lung metastases. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 3482
    The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21.

    The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21. by Bryan S. Margulies (21492667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3483
    Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1.

    Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. by Mucahit Gemici (21519313)

    Published 2025
    Save to List
    Saved in:
  4. 3484
    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2.

    One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. by Mucahit Gemici (21519313)

    Published 2025
    Save to List
    Saved in:
  5. 3485
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 3486
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 3487
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 3488
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 3489
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 3490
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 3491
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 3492
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 3493
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 3494
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 3495
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 3496
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 3497
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 3498
    Root mean square deviation of wild-type AKR1C3 (green line) and mutant (H5Q) AKR1C3 (purple line) proteins.

    Root mean square deviation of wild-type AKR1C3 (green line) and mutant (H5Q) AKR1C3 (purple line) proteins. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 3499
    The solvent accessible surface area (SASA) of wild-type (green line) AKR1C3 (complexed with the ligand, NADPH) was lower than that of the mutant (purple line) AKR1C3 (complexed with the ligand, NADPH).

    The solvent accessible surface area (SASA) of wild-type (green line) AKR1C3 (complexed with the ligand, NADPH) was lower than that of the mutant (purple line) AKR1C3 (complexed wit... by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 3500
    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects.

    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: